Will peripherally restricted kappa‐opioid receptor agonists (pKORAs) relieve pain with less opioid adverse effects and abuse potential? - Albert‐Vartanian - 2016 - Journal of Clinical Pharmacy and Therapeutics - Wiley Online Library
Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram
EX-99.2
Frontiers | The Kappa Opioid Receptor: From Addiction to Depression, and Back
Pharmaceuticals | Free Full-Text | Therapeutic Potential of Kappa Opioid Agonists
κ-opioid receptor - Wikipedia
Discovery of Small Molecule Kappa Opioid Receptor Agonist and Antagonist Chemotypes through a HTS and Hit Refinement Strategy | ACS Chemical Neuroscience
Biased agonists of the kappa opioid receptor suppress pain and itch without causing sedation or dysphoria | Science Signaling
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Nalfurafine, a G-Protein–Biased KOR (Kappa Opioid Receptor) Agonist, Enhances the Diuretic Response and Limits Electrolyte Losses to Standard-of-Care Diuretics | Hypertension
The Role of Dynorphin and the Kappa Opioid Receptor in the Symptomatology of Schizophrenia: A Review of the Evidence
Mu and delta, but not kappa, opioid agonists induce spastic paraparesis after a short period of spinal cord ischaemia in rats† - British Journal of Anaesthesia
Opioids: classification, uses, action and dependence - MedicalVerge
Opioid Receptor | kappa, mu Opioid Receptor
Kappa Opiate Receptor Agonist - an overview | ScienceDirect Topics
Enhancing Remyelination through a Novel Opioid-Receptor Pathway | Journal of Neuroscience
Mu Agonist Opioids and Kappa Opioids | Download Table
Opioid Receptors Mnemonic | Epomedicine
Kappa Receptors – Opioid Peptides
Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold | ACS Chemical Neuroscience
κ-opioid receptor - Wikipedia
Cara Therapeutics: Scratching An Itch Left Unscratched (NASDAQ:CARA) | Seeking Alpha
